Two Sigma Investments’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-29,671
| Closed | -$33.2K | – | 2903 |
|
2023
Q2 | $33.2K | Sell |
29,671
-14,831
| -33% | -$16.6K | ﹤0.01% | 2789 |
|
2023
Q1 | $46.3K | Sell |
44,502
-56,327
| -56% | -$58.6K | ﹤0.01% | 2694 |
|
2022
Q4 | $113K | Sell |
100,829
-67,374
| -40% | -$75.5K | ﹤0.01% | 2433 |
|
2022
Q3 | $190K | Sell |
168,203
-43,682
| -21% | -$49.3K | ﹤0.01% | 2069 |
|
2022
Q2 | $311K | Sell |
211,885
-122,615
| -37% | -$180K | ﹤0.01% | 1950 |
|
2022
Q1 | $766K | Sell |
334,500
-605,799
| -64% | -$1.39M | ﹤0.01% | 1778 |
|
2021
Q4 | $2.59M | Buy |
940,299
+112,800
| +14% | +$310K | 0.01% | 1212 |
|
2021
Q3 | $4.97M | Sell |
827,499
-257,976
| -24% | -$1.55M | 0.01% | 913 |
|
2021
Q2 | $5.29M | Buy |
1,085,475
+363,267
| +50% | +$1.77M | 0.01% | 893 |
|
2021
Q1 | $1.78M | Buy |
722,208
+572,969
| +384% | +$1.42M | ﹤0.01% | 1324 |
|
2020
Q4 | $409K | Sell |
149,239
-61,513
| -29% | -$169K | ﹤0.01% | 1639 |
|
2020
Q3 | $325K | Buy |
210,752
+87,511
| +71% | +$135K | ﹤0.01% | 1559 |
|
2020
Q2 | $232K | Buy |
+123,241
| New | +$232K | ﹤0.01% | 1699 |
|
2019
Q3 | – | Sell |
-65,842
| Closed | -$64K | – | 2012 |
|
2019
Q2 | $64K | Sell |
65,842
-1,206
| -2% | -$1.17K | ﹤0.01% | 1963 |
|
2019
Q1 | $93K | Sell |
67,048
-141,107
| -68% | -$196K | ﹤0.01% | 2009 |
|
2018
Q4 | $223K | Buy |
208,155
+113,046
| +119% | +$121K | ﹤0.01% | 1840 |
|
2018
Q3 | $585K | Buy |
+95,109
| New | +$585K | ﹤0.01% | 1545 |
|
2018
Q2 | – | Sell |
-103,991
| Closed | -$1.12M | – | 2084 |
|
2018
Q1 | $1.12M | Buy |
+103,991
| New | +$1.12M | ﹤0.01% | 1278 |
|